Cosmo Bio Co (3386.T) Stock Price

Cosmo Bio Co Price

CLOSED
1,232.00JPY-2.00 (-0.16 %)
Market closed

Over the last 19 years Cosmo Bio Co grew revenue by 3.2% annually, reaching 10.77 B JPY. Earnings per share have declined at 1.2% per year over the last 19 years. For Cosmo Bio Co, the net margin of 3.1% is down versus 8.0% a few years ago. At today's price the dividend yield works out to roughly 4.06%. The payout ratio is around 84% of earnings. The stock trades about 13% above its 52-week low.

Cosmo Bio Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Cosmo Bio Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cosmo Bio Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cosmo Bio Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Cosmo Bio Co Stock Price History
DateCosmo Bio Co Price
7/17/20261,232.00 JPY
7/16/20261,234.00 JPY
7/15/20261,236.00 JPY
7/14/20261,246.00 JPY
7/13/20261,254.00 JPY
7/10/20261,255.00 JPY
7/9/20261,258.00 JPY
7/8/20261,262.00 JPY
7/7/20261,269.00 JPY
7/6/20261,277.00 JPY
7/3/20261,267.00 JPY
7/2/20261,276.00 JPY
7/1/20261,311.00 JPY
6/30/20261,230.00 JPY
6/29/20261,221.00 JPY
6/26/20261,249.00 JPY
6/25/20261,237.00 JPY
6/24/20261,235.00 JPY
6/23/20261,239.00 JPY
6/22/20261,243.00 JPY
6/19/20261,231.00 JPY
6/18/20261,247.00 JPY
6/17/20261,230.00 JPY
6/16/20261,234.00 JPY
6/15/20261,228.00 JPY
6/12/20261,230.00 JPY
6/11/20261,226.00 JPY
6/10/20261,224.00 JPY
6/9/20261,213.00 JPY
6/8/20261,212.00 JPY
6/5/20261,223.00 JPY
6/4/20261,225.00 JPY
6/3/20261,219.00 JPY
6/2/20261,204.00 JPY
6/1/20261,222.00 JPY
5/29/20261,232.00 JPY
5/28/20261,239.00 JPY
5/27/20261,237.00 JPY
5/26/20261,230.00 JPY
5/25/20261,233.00 JPY
5/22/20261,235.00 JPY
5/21/20261,241.00 JPY
5/20/20261,231.00 JPY
5/19/20261,242.00 JPY
5/18/20261,233.00 JPY
5/15/20261,240.00 JPY
5/14/20261,241.00 JPY
5/13/20261,244.00 JPY
5/12/20261,244.00 JPY
5/11/20261,252.00 JPY
5/8/20261,264.00 JPY
5/7/20261,255.00 JPY
5/1/20261,262.00 JPY
4/30/20261,275.00 JPY
4/28/20261,272.00 JPY
4/27/20261,274.00 JPY
4/24/20261,246.00 JPY
4/23/20261,241.00 JPY
4/22/20261,253.00 JPY
4/21/20261,253.00 JPY
4/20/20261,283.00 JPY
4/17/20261,296.00 JPY
4/16/20261,296.00 JPY
4/15/20261,279.00 JPY
4/14/20261,281.00 JPY
4/13/20261,271.00 JPY
4/10/20261,272.00 JPY
4/9/20261,298.00 JPY
4/8/20261,318.00 JPY
4/7/20261,276.00 JPY
4/6/20261,288.00 JPY
4/3/20261,287.00 JPY
4/2/20261,277.00 JPY
4/1/20261,288.00 JPY
3/31/20261,261.00 JPY
3/30/20261,252.00 JPY
3/27/20261,256.00 JPY
3/26/20261,253.00 JPY
3/25/20261,281.00 JPY
3/24/20261,271.00 JPY
3/23/20261,258.00 JPY
3/19/20261,311.00 JPY
3/18/20261,338.00 JPY
3/17/20261,322.00 JPY
3/16/20261,316.00 JPY
3/13/20261,334.00 JPY
3/12/20261,341.00 JPY
3/11/20261,359.00 JPY
3/10/20261,357.00 JPY
3/9/20261,316.00 JPY
3/6/20261,362.00 JPY
3/5/20261,368.00 JPY
2/26/20261,367.00 JPY
2/25/20261,389.00 JPY
2/24/20261,367.00 JPY
2/20/20261,412.00 JPY
2/19/20261,318.00 JPY
2/18/20261,310.00 JPY
2/17/20261,303.00 JPY
2/16/20261,307.00 JPY
2/13/20261,346.00 JPY
2/12/20261,348.00 JPY
2/10/20261,314.00 JPY
2/9/20261,304.00 JPY
2/6/20261,311.00 JPY
2/5/20261,306.00 JPY
2/4/20261,307.00 JPY
2/3/20261,317.00 JPY
2/2/20261,301.00 JPY
1/30/20261,339.00 JPY
1/29/20261,319.00 JPY
1/28/20261,333.00 JPY
1/27/20261,318.00 JPY
1/26/20261,315.00 JPY
1/23/20261,329.00 JPY
1/22/20261,302.00 JPY
1/21/20261,299.00 JPY
1/20/20261,316.00 JPY
1/19/20261,332.00 JPY
1/16/20261,317.00 JPY
1/15/20261,332.00 JPY
1/14/20261,318.00 JPY
1/13/20261,340.00 JPY
1/9/20261,324.00 JPY
1/8/20261,334.00 JPY
1/7/20261,328.00 JPY
1/6/20261,305.00 JPY
1/5/20261,304.00 JPY
12/30/20251,304.00 JPY
12/29/20251,331.00 JPY
12/26/20251,340.00 JPY
12/25/20251,336.00 JPY
12/24/20251,337.00 JPY
12/23/20251,334.00 JPY
12/22/20251,316.00 JPY
12/19/20251,343.00 JPY
12/18/20251,340.00 JPY
12/17/20251,335.00 JPY
12/16/20251,343.00 JPY
12/15/20251,364.00 JPY
12/12/20251,359.00 JPY
12/11/20251,333.00 JPY
12/10/20251,362.00 JPY
12/9/20251,370.00 JPY
12/8/20251,361.00 JPY
12/5/20251,358.00 JPY
12/4/20251,398.00 JPY
12/3/20251,404.00 JPY
12/2/20251,390.00 JPY
12/1/20251,390.00 JPY
11/28/20251,423.00 JPY
11/27/20251,375.00 JPY
11/26/20251,398.00 JPY
11/25/20251,375.00 JPY
11/21/20251,378.00 JPY
11/20/20251,355.00 JPY
11/19/20251,405.00 JPY
11/18/20251,422.00 JPY
11/17/20251,439.00 JPY
11/14/20251,351.00 JPY
11/13/20251,093.00 JPY
11/12/20251,102.00 JPY
11/11/20251,097.00 JPY
11/10/20251,102.00 JPY
11/7/20251,117.00 JPY
11/6/20251,117.00 JPY
11/5/20251,114.00 JPY
11/4/20251,109.00 JPY
10/31/20251,144.00 JPY
10/30/20251,164.00 JPY
10/29/20251,163.00 JPY
10/28/20251,174.00 JPY
10/27/20251,177.00 JPY
10/24/20251,178.00 JPY
10/23/20251,190.00 JPY
10/22/20251,190.00 JPY
10/21/20251,190.00 JPY
10/20/20251,198.00 JPY
10/17/20251,190.00 JPY
10/16/20251,190.00 JPY
10/15/20251,205.00 JPY
10/14/20251,205.00 JPY
10/10/20251,220.00 JPY
10/9/20251,214.00 JPY
10/8/20251,221.00 JPY
10/7/20251,224.00 JPY
10/6/20251,230.00 JPY
10/3/20251,220.00 JPY
10/2/20251,201.00 JPY
10/1/20251,215.00 JPY
9/30/20251,221.00 JPY
9/29/20251,220.00 JPY
9/26/20251,216.00 JPY
9/25/20251,228.00 JPY
9/24/20251,240.00 JPY
9/22/20251,224.00 JPY
9/19/20251,233.00 JPY
9/18/20251,233.00 JPY
9/17/20251,237.00 JPY
9/16/20251,236.00 JPY
9/12/20251,241.00 JPY
9/11/20251,203.00 JPY
9/10/20251,202.00 JPY
9/9/20251,205.00 JPY
9/8/20251,211.00 JPY
9/5/20251,200.00 JPY
9/4/20251,202.00 JPY
9/3/20251,195.00 JPY
9/2/20251,196.00 JPY
9/1/20251,194.00 JPY
8/29/20251,173.00 JPY
8/28/20251,174.00 JPY
8/27/20251,191.00 JPY
8/26/20251,190.00 JPY
8/25/20251,180.00 JPY
8/22/20251,168.00 JPY
8/21/20251,167.00 JPY
8/20/20251,179.00 JPY
8/19/20251,165.00 JPY
8/18/20251,177.00 JPY
8/15/20251,167.00 JPY
8/14/20251,168.00 JPY
8/13/20251,188.00 JPY
8/12/20251,178.00 JPY
8/8/20251,166.00 JPY
8/7/20251,169.00 JPY
8/6/20251,170.00 JPY
8/5/20251,184.00 JPY
8/4/20251,168.00 JPY
8/1/20251,180.00 JPY
7/31/20251,185.00 JPY
7/30/20251,187.00 JPY
7/29/20251,181.00 JPY
7/28/20251,183.00 JPY
7/25/20251,174.00 JPY
7/24/20251,184.00 JPY
7/23/20251,179.00 JPY
7/22/20251,173.00 JPY
Access this data via the Eulerpool API
Get Free API Key

Cosmo Bio Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
7.26 B JPY
328.00 M JPY
260.00 M JPY
Jan 1, 2019
7.59 B JPY
405.00 M JPY
237.00 M JPY
Jan 1, 2020
8.09 B JPY
752.00 M JPY
674.00 M JPY
Jan 1, 2021
9.23 B JPY
1.05 B JPY
737.00 M JPY
Jan 1, 2022
9.55 B JPY
816.00 M JPY
517.00 M JPY
Jan 1, 2023
9.34 B JPY
519.00 M JPY
442.00 M JPY
Jan 1, 2024
10.04 B JPY
318.00 M JPY
262.00 M JPY
Jan 1, 2025
10.77 B JPY
343.00 M JPY
337.00 M JPY

Cosmo Bio Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 20, 2026, 10:49 PM
 
REVENUEB JPY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB JPY
EBITB JPY
EBIT MARGIN%
NET INCOMEM JPY
NET INCOME GROWTH%
DIV.JPY
DIV. GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
6.687.197.247.057.247.367.437.077.267.598.099.239.559.3410.0410.77
26.397.730.68-2.642.621.690.95-4.832.734.536.6114.083.49-2.237.467.26
42.6844.2743.9737.1833.5032.3637.3235.8436.6237.9438.9539.6436.0234.8033.1734.39
2.853.183.182.622.422.382.772.532.662.883.153.663.443.253.333.70
0.700.890.770.270.160.200.510.190.330.410.751.050.820.520.320.34
10.5212.4010.693.842.162.726.922.734.525.349.2911.358.545.563.173.19
373.00458.00411.00313.00201.00230.00254.00237.00260.00237.00674.00737.00517.00442.00262.00337.00
172.2622.79-10.26-23.84-35.7814.4310.43-6.699.70-8.85184.399.35-29.85-14.51-40.7228.63
24.002,000.00812.0020.0020.0014.0018.0014.0014.0014.0034.0036.0036.0030.0050.0050.00
9.098,233.33-59.40-97.54–-30.0028.57-22.22––142.865.88–-16.6766.67–
6.006.005.905.905.935.935.935.935.935.935.935.815.815.835.825.69
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Cosmo Bio Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cosmo Bio Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cosmo Bio Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Cosmo Bio Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cosmo Bio Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Cosmo Bio Co stock margins

The Cosmo Bio Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cosmo Bio Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cosmo Bio Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
36.62 %
4.52 %
3.58 %
Jan 1, 2019
37.94 %
5.34 %
3.12 %
Jan 1, 2020
38.95 %
9.29 %
8.33 %
Jan 1, 2021
39.64 %
11.35 %
7.98 %
Jan 1, 2022
36.02 %
8.54 %
5.41 %
Jan 1, 2023
34.80 %
5.56 %
4.73 %
Jan 1, 2024
33.17 %
3.17 %
2.61 %
Jan 1, 2025
34.39 %
3.19 %
3.13 %

Cosmo Bio Co Stock Revenue, EBIT, Earnings per Share

The Cosmo Bio Co earnings per share therefore indicates how much revenue Cosmo Bio Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
1,224.87 JPY
55.33 JPY
43.86 JPY
Jan 1, 2019
1,280.36 JPY
68.32 JPY
39.98 JPY
Jan 1, 2020
1,365.05 JPY
126.86 JPY
113.70 JPY
Jan 1, 2021
1,589.14 JPY
180.42 JPY
126.88 JPY
Jan 1, 2022
1,645.57 JPY
140.56 JPY
89.06 JPY
Jan 1, 2023
1,602.47 JPY
89.05 JPY
75.83 JPY
Jan 1, 2024
1,725.79 JPY
54.68 JPY
45.05 JPY
Jan 1, 2025
1,893.02 JPY
60.31 JPY
59.26 JPY

Cosmo Bio Co business model & stock analysis

Cosmo Bio Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Cosmo Bio Co historical P/E ratio, EBIT multiple, and P/S ratio

Cosmo Bio Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Cosmo Bio Co shares outstanding

The number of shares of Cosmo Bio Co was 5.69 M in 2025. This indicates how many shares Cosmo Bio Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
5.93 M Stocks
Jan 1, 2019
5.93 M Stocks
Jan 1, 2020
5.93 M Stocks
Jan 1, 2021
5.81 M Stocks
Jan 1, 2022
5.81 M Stocks
Jan 1, 2023
5.83 M Stocks
Jan 1, 2024
5.82 M Stocks
Jan 1, 2025
5.69 M Stocks

Cosmo Bio Co stock splits

In Cosmo Bio Co's history, there have been no stock splits.

Cosmo Bio Co Dividend History

21 years of dividend payments

YearAnnual DividendYoY ChangePayments
202550.00JPY 0.0%2×
Jun 27, 202525.00JPY↓ 30.6%1/2
Dec 29, 202525.00JPY 0.0%2/2
202450.00JPY↑ 66.7%2×
202330.00JPY↓ 16.7%2×
202236.00JPY 0.0%2×
202136.00JPY↑ 5.9%2×
202034.00JPY↑ 142.9%2×
201914.00JPY 0.0%2×
201814.00JPY 0.0%2×
201714.00JPY↓ 22.2%2×
201618.00JPY↑ 28.6%2×

Cosmo Bio Co dividend history and estimates

In 2025, Cosmo Bio Co paid a dividend amounting to 50.00 JPY. Dividend means that Cosmo Bio Co distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2018
14.00 JPY
0.00 JPY
Jan 1, 2019
14.00 JPY
0.00 JPY
Jan 1, 2020
34.00 JPY
0.00 JPY
Jan 1, 2021
36.00 JPY
0.00 JPY
Jan 1, 2022
36.00 JPY
0.00 JPY
Jan 1, 2023
30.00 JPY
0.00 JPY
Jan 1, 2024
50.00 JPY
0.00 JPY
Jan 1, 2025
50.00 JPY
0.00 JPY

Cosmo Bio Co dividend payout ratio

In 2025, Cosmo Bio Co had a payout ratio of 84.38%. The payout ratio indicates the percentage of the company's profits that Cosmo Bio Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
31.92 %
Jan 1, 2019
35.02 %
Jan 1, 2020
29.90 %
Jan 1, 2021
28.37 %
Jan 1, 2022
40.42 %
Jan 1, 2023
39.56 %
Jan 1, 2024
110.99 %
Jan 1, 2025
84.38 %
Price targets and forecasts for Cosmo Bio Co are not yet available.

Cosmo Bio Co shareholder structure

% Name
19.04132%
Tokyo Small and Medium Business Investment & Consultation Co., Ltd.
Tokyo Small and Medium Business Investment & Consultation Co., Ltd.
7.24463%
UH Partners 2, Inc.
UH Partners 2, Inc.
7.20496%
Hikari Tsushin KK
Hikari Tsushin KK
2.35207%
Cosmo Bio Company Ltd. Employees
Cosmo Bio Company Ltd. Employees
1.64793%
UH Partners 3, Inc.
UH Partners 3, Inc.
1.58678%
Sakurai (Haruhisa)
Sakurai (Haruhisa)

Cosmo Bio Co Executives and Management Board

NS

Mr. Norihiko Shibayama

(54)

President, Representative Director · since 2017

MH

Mr. Masanori Hayashi

Director of Finance, Director · since 2023

JT

Ms. Junko Tochigi

(49)

Managing Director, Director of Planning, President of Subsidiary · since 2017

KH

Mr. Ken Hasegawa

Executive Officer

JH

Mr. Junichiro Haraguchi

Independent Director

Frequently asked questions about Cosmo Bio Co

Converted at the current exchange rate, the Cosmo Bio Co share trades at 6.63 EUR (1,232.00 JPY).

All fundamentals and in-depth analysis of Cosmo Bio Co

Our stock analysis for Cosmo Bio Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cosmo Bio Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Cosmo Bio Co Stock
Cosmo Bio Co Revenue→
Cosmo Bio Co Stock
Cosmo Bio Co Net Income→
Cosmo Bio Co Stock
Cosmo Bio Co P/E→
Cosmo Bio Co Stock
Cosmo Bio Co P/S→
Cosmo Bio Co Stock
Cosmo Bio Co EBIT→
Cosmo Bio Co Stock
Cosmo Bio Co Dividend→
Cosmo Bio Co Stock
Cosmo Bio Co Directors Dealings→
Cosmo Bio Co Stock
Cosmo Bio Co Stocks→
Cosmo Bio Co Stock
Cosmo Bio Co Market capitalization→
Cosmo Bio Co Stock
Cosmo Bio Co Debt→
Cosmo Bio Co Stock
Cosmo Bio Co Liabilities→
Cosmo Bio Co Stock
Cosmo Bio Co Equity→
Cosmo Bio Co Stock
Cosmo Bio Co AAQS→
Cosmo Bio Co Stock
Cosmo Bio Co Employees→
Cosmo Bio Co Stock
Cosmo Bio Co ROE→
Cosmo Bio Co Stock
Cosmo Bio Co ROA→
Cosmo Bio Co Stock
Cosmo Bio Co ROCE→
Cosmo Bio Co Stock
Cosmo Bio Co News→
Cosmo Bio Co Stock
Cosmo Bio Co Analyst Price Targets→

Health Stocks

Cosmo PharmaceuticalsCorvus PharmaceuticalsCosmos HealthCorVelCovalon TechnologiesCorrelate EnergyCowealth Medical China CoCorMedixCowealth Medical Holding CoCorline BiomedicalCoya TherapeuticsCorix BioscienceAll Stocks A–Z →